Scott Myslinski began his career in contract drug manufacturing in 2012 and joined Altasciences in 2014 as a Manufacturing Associate.

Screening for Pre-Existing Antibodies to Adenovirus for Nonclinical Gene Therapy Programs

Subscribe to